Bridgefront Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,270
| Closed | -$173K | – | 470 |
|
|
2023
Q4 | $173K | Buy |
+21,270
| New | +$173K | 0.13% | 311 |
|
|
2023
Q2 | – | Sell |
-38,528
| Closed | -$235K | – | 565 |
|
|
2023
Q1 | $235K | Buy |
+38,528
| New | +$235K | 0.14% | 284 |
|
|
2021
Q3 | – | Sell |
-9,391
| Closed | -$244K | – | 508 |
|
|
2021
Q2 | $244K | Sell |
9,391
-2,287
| -20% | -$59.4K | 0.09% | 428 |
|
|
2021
Q1 | $370K | Buy |
+11,678
| New | +$370K | 0.12% | 350 |
|